Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PHBI Pharmagreen Biotech Inc (PK)

0.00 (0.00%)
Last Updated: 10:58:33
Delayed by 15 minutes


Draw Mode:

Volume 658,800
Bid Price 0.0008
Ask Price 0.0009
News -
Day High 0.0009


52 Week Range


Day Low 0.00085
Company Name Stock Ticker Symbol Market Type
Pharmagreen Biotech Inc (PK) PHBI OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0009 10:58:33
Open Price Low Price High Price Close Price Prev Close
0.0009 0.00085 0.0009 0.0009
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8 658,800 $ 0.00086 $ 566 - 0.000195 - 0.007
Last Trade Time Type Quantity Stock Price Currency
10:58:33 15,000 $ 0.0009 USD

Pharmagreen Biotech Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 463.96M 267.09M 3k -569k -0.00 0.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Pharmagreen Biotech (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No PHBI Message Board. Create One! See More Posts on PHBI Message Board See More Message Board Posts

Historical PHBI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00080.00090.00070.00082681,950,1050.000112.50%
1 Month0.00070.00090.00060.00071652,872,1150.000228.57%
3 Months0.00060.0010.00050.00071552,272,3390.000350.00%
6 Months0.00110.001450.0001950.000712110,003,793-0.0002-18.18%
1 Year0.00590.0070.0001950.00084395,725,632-0.005-84.75%
3 Years0.03870.060.0001950.00948072,749,438-0.0378-97.67%
5 Years2.383.000.0001950.0174482,838,608-2.38-99.96%

Pharmagreen Biotech (PK) Description

Pharmagreen Biotech Inc. (OTC Markets: PHBI) is developing its line of nutraceutical products, a proprietary blend of therapeutic plants and mushrooms. Pharmagreen's first new product, MaxGenomic(TM) Supplement, is a proprietary blend, formulated in the U. S. A., of nine medicinal mushrooms and six medicinal plants to help support the human mind and body. This supplement is produced in a U.S.A cGMP facility, in enteric capsules to enhance the bioavailability of the MaxGenomic(TM) supplement. Pharmagreen is also completing its research for its elixir, sublingual version, to provide immediate help and support to those who push their mental and physical capacity to their limits. Utilizing the Company's expertise in plant genetics, tissue culture, Pharmagreen's transgenic program uses the current technologies to research and create nutraceutical formulations as daily supplements, with the potential to improve lives and address a wide variety of aliments.

Your Recent History

Delayed Upgrade Clock